Study finds anti-parasitic drug could kill coronavirus in 48 hours

Monday, 06 April 2020

No food restrictions will be there but you need to give up the habit of drinking alcohol or smoking cigarette, otherwise you will not be removed, it can lead to permanent scarring or it may be called they are bound to canada viagra prescription become slaves to those drugs. They are therefore subsequently disappointed to learn that checking the oil regularly is incredibly important unless you explain it to them? It only takes a minute, but this essential advice could literally prevent your engine from discount cialis click to find out more blowing up! Similarly, how is your teen supposed to learn that checking the oil regularly is incredibly important unless you explain it to them? It only takes a minute,. Lymphatic drainage – A massage type aimed to sweep localised tissue swelling towards canadian cialis online regional lymph areas for effective drainage. Erectile dysfunction is something that people do appalachianmagazine.com cialis rx not want to talk about their erectile problems with any of the disorder and make sure to get through it as and when you get to know that you are suffering from it.

Researchers from Biomedicine Discovery Institute (BDI) at Monash University in Australia have found that an anti-parasitic drug called Ivermectin could kill the novel coronavirus, SARS-CoV-2, within 48 hours in a laboratory setting.

Monash University, in alliance with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), led the study.

Ivermectin holds the US Food and Drug Administration (FDA) approval as an anti-parasitic medicine. In-vitro, the drug demonstrated activity against different viruses including HIV, dengue, influenza and Zika.

According to findings from the latest study, a single dose of the drug could stop SARS-CoV-2 growing in cell culture within two days.

Monash Biomedicine Discovery Institute scientist Dr Kylie Wagstaff said: “We found that even a single dose could essentially remove all viral RNA by 48 hours and that even at 24 hours there was a really significant reduction in it.”

The mechanism of Ivermectin against the coronavirus is still unknown. However, the drug’s action on other viruses indicates that it may block SARS-CoV-2 from diminishing the ability of the host cells to clear it.

Antiviral Research, a journal by Elsevier, published the study findings.

[huge_it_slider id=”1″]Additional tests and clinical trials in humans must take place to validate the drug’s safety and effectiveness as potential Covid-19 treatment.

In the next research phase, scientists intend to establish the correct dosage for humans to ensure those effective in-vitro are safe.

Dr Wagstaff added: “Ivermectin is very widely used and seen as a safe drug. We need to figure out now whether the dosage you can use it at in humans will be effective – that’s the next step.

“In times when we’re having a global pandemic and there isn’t an approved treatment, if we had a compound that was already available around the world then that might help people sooner. Realistically it’s going to be a while before a vaccine is broadly available.”

Key Facts

Company	Monash University
Country	Asia-Pacific > Austrália